Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Fancy who wrote (4351)	5/20/1998 7:53:00 AM
From: Bryan Arnold	Read Replies (2) \| Respond to of 6136

I still can't believe that they predict no revenues from the cancer drug in Phase II/III. Even in their report, they comment that it will take 2 years to complete, so that would mean completion in the middle of the year 2000 with hopefully, filing the end of the year and approval sometime in 2001. If you go according to their plan. So wouldn't you have to at least throw some sort of revenues in their by the year 2002. I realize it would be hard to predict but you would think that they at least would put something in there. Bryan